Interstitial Lung Disease as a Late Occurrence in Ocrelizumab-Treated Patients With Multiple Sclerosis
This case series describes 6 cases of interstitial lung disease among patients with multiple sclerosis receiving long-term treatment with ocrelizumab.
Authors
- Krzysztof Selmaj (ORCID: https://orcid.org/0000-0003-1213-7218)
- Anna Żurawska (ORCID: https://orcid.org/0000-0001-8204-0724)
- Katarzyna Rzeszutek
- Anne H. Cross (ORCID: https://orcid.org/0000-0003-0829-7569)
- Agnieszka Rogozińska-Zawiślak
Institutions
- Washington University in St. Louis (US)
- University of Łódź (PL)
- Pulmonary Associates (US)
- University of Warmia and Mazury in Olsztyn (PL)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2026-04-06
- DOI
- https://doi.org/10.1001/jamaneurol.2026.0548
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00